Search Results | Clear Search | Previous (in doc) | Next (in doc) | Prev Doc | Next Doc
B.C. Reg. 103/2023
M109/2023
Deposited April 18, 2023
This consolidation is current to November 11, 2025.
Link to consolidated regulation (PDF)
Link to Point in Time

Pharmacy Operations and Drug Scheduling Act

Drug Schedules (Limits on Sale) Regulation

[Last amended July 17, 2025 by B.C. Reg. 138/2025]

Limits on sale

1   A drug listed in the table below must not be sold from a pharmacy to a person unless at least one of the following conditions is met:

(a) the person is a citizen or permanent resident of Canada;

(b) the drug is sold directly to the person, while the person is on the premises of the pharmacy.

Drug
Dulaglutide
Semaglutide
Tirzepatide

[am. B.C. Reg. 138/2025.]

[Provisions relevant to the enactment of this regulation: Pharmacy Operations and Drug Scheduling Act, S.B.C. 2003, c. 77, s. 23 (4).]